Delivery Order SPE2DB22D3010-SPE2DB25FP3KA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Nucynta 75 mg tablets (100 count) with a ceiling value of $2,451.24. This is a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Nucynta 75 mg tablets (100 count) with a ceiling value of $1,432.38. This is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competitively awarded. This delivery order is a...
- The Defense Logistics Agency awarded a $1,837.60 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Nucynta 50 mg tablets (100-count packages). This firm fixed-price contract, which is not set-aside and competitively awarded, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is the company's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Nucynta 50 mg tablets (100 count) with a ceiling value of $1,225.04. This firm fixed-price delivery order, with an ultimate completion date of July 23, 2025, represents a direct fulfillment of pharmaceutical needs through the federal medical supply chain. The contract is not set-aside and was competitively awarded, reflecting AmerisourceBergen's established capability as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) valued at $2,944.08 under a firm fixed-price contract. This delivery order represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling and extends through December 2026. The award was competitively...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Nucynta 100 mg tablets (100 count) with a ceiling value of $2,251.73. This firm fixed-price delivery order, with an ultimate completion date of August 21, 2025, represents a competitively awarded non-set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Nucynta 50 mg tablets (100-count package) with a ceiling value of $1,225.04. This firm fixed-price delivery order, which is expected to be completed by August 22, 2025, represents a non-competitive, non-set-aside award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta 50 mg tablets in quantities of 100 units, valued at $1,747.02. This competitively awarded, firm fixed-price contract was established on August 1, 2025, with an ultimate completion date of August 4, 2025. The order is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child delivery order under a larger contract vehicle....
- The Defense Logistics Agency awarded a delivery order valued at $1,899.74 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 150 mg tablets (60-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract action under...
- The Defense Logistics Agency awarded a delivery order valued at $2,849.76 to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Nucynta 100 mg tablets (100-count). The contract reflects a firm fixed-price arrangement with an ultimate completion date of August 11, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This non-set-aside delivery order was competitively awarded and represents a routine pharmaceutical procurement within...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB25FP3KADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Nucynta 50 mg tablets (100 units) with a ceiling value of $1,225.04. This competitively awarded, firm fixed-price delivery order is not subject to any set-aside designation and is scheduled for completion by September 5, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor. This delivery order represents a child action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. The current award for Nucynta, an opioid pain management medication, exemplifies the type of controlled pharmaceutical products delivered through this contract framework to support the Defense Health Agency and related federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/4/25 |